2-[2-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-3-pyridinyl]-1,3-thiazole;2-[2-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-4-pyridinyl]-1,3-thiazole;2-[6-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-3-pyridinyl]-1,3-thiazole;2-[4-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]-2-pyridin-2-ylbenzene-3-id-1-yl]-1,3-thiazole;tetrakis(platinum(2+))

C136H84N20Pt4S4 — CID 157122732

IUPAC2-[2-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-3-pyridinyl]-1,3-thiazole;2-[2-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-4-pyridinyl]-1,3-thiazole;2-[6-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-3-pyridinyl]-1,3-thiazole;2-[4-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]-2-pyridin-2-ylbenzene-3-id-1-yl]-1,3-thiazole;tetrakis(platinum(2+))
SMILESCn1c(-c2[c-]c3c(cc2)c2ccccc2n3-c2[c-]c(-c3cc(-c4nccs4)ccn3)ccc2)nc2ccccc21.Cn1c(-c2[c-]c3c(cc2)c2ccccc2n3-c2[c-]c(-c3ccc(-c4nccs4)cn3)ccc2)nc2ccccc21.Cn1c(-c2[c-]c3c(cc2)c2ccccc2n3-c2[c-]c(-c3ccccn3)c(-c3nccs3)cc2)nc2ccccc21.Cn1c(-c2[c-]c3c(cc2)c2ccccc2n3-c2[c-]c(-c3ncccc3-c3nccs3)ccc2)nc2ccccc21.[Pt+2].[Pt+2].[Pt+2].[Pt+2]
InChIInChI=1S/4C34H21N5S.4Pt/c1-38-30-14-5-3-12-28(30)37-33(38)23-15-16-26-25-10-2-4-13-29(25)39(31(26)21-23)24-9-6-8-22(20-24)32-27(11-7-17-35-32)34-36-18-19-40-34;1-38-31-12-5-3-10-29(31)37-33(38)23-13-15-27-26-9-2-4-11-30(26)39(32(27)20-23)25-8-6-7-22(19-25)28-16-14-24(21-36-28)34-35-17-18-40-34;1-38-31-12-5-3-10-28(31)37-33(38)23-13-14-27-26-9-2-4-11-30(26)39(32(27)21-23)25-8-6-7-22(19-25)29-20-24(15-16-35-29)34-36-17-18-40-34;1-38-31-12-5-3-10-29(31)37-33(38)22-13-15-25-24-8-2-4-11-30(24)39(32(25)20-22)23-14-16-26(34-36-18-19-40-34)27(21-23)28-9-6-7-17-35-28;;;;/h2-19H,1H3;2-18,21H,1H3;2-18,20H,1H3;2-19H,1H3;;;;/q4*-2;4*+2
InChIKeyGXSIVMMBVLLHGN-UHFFFAOYSA-N
MW2906.89 g/mol
LogP32.48
Rot. Bonds16

About 2-[2-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-3-pyridinyl]-1,3-thiazole;2-[2-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-4-pyridinyl]-1,3-thiazole;2-[6-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-3-pyridinyl]-1,3-thiazole;2-[4-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]-2-pyridin-2-ylbenzene-3-id-1-yl]-1,3-thiazole;tetrakis(platinum(2+))

2-[2-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-3-pyridinyl]-1,3-thiazole;2-[2-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-4-pyridinyl]-1,3-thiazole;2-[6-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-3-pyridinyl]-1,3-thiazole;2-[4-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]-2-pyridin-2-ylbenzene-3-id-1-yl]-1,3-thiazole;tetrakis(platinum(2+)) (PubChem CID 157122732) has the molecular formula C136H84N20Pt4S4 and a molecular weight of 2906.89 g/mol. Its IUPAC name is 2-[2-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-3-pyridinyl]-1,3-thiazole;2-[2-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-4-pyridinyl]-1,3-thiazole;2-[6-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-3-pyridinyl]-1,3-thiazole;2-[4-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]-2-pyridin-2-ylbenzene-3-id-1-yl]-1,3-thiazole;tetrakis(platinum(2+)).

Molecular Properties

Compound Name2-[2-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-3-pyridinyl]-1,3-thiazole;2-[2-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-4-pyridinyl]-1,3-thiazole;2-[6-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-3-pyridinyl]-1,3-thiazole;2-[4-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]-2-pyridin-2-ylbenzene-3-id-1-yl]-1,3-thiazole;tetrakis(platinum(2+))
PubChem CID157122732
Molecular FormulaC136H84N20Pt4S4
Molecular Weight2906.89 g/mol
Exact Mass2904.47
IUPAC Name2-[2-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-3-pyridinyl]-1,3-thiazole;2-[2-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-4-pyridinyl]-1,3-thiazole;2-[6-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-3-pyridinyl]-1,3-thiazole;2-[4-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]-2-pyridin-2-ylbenzene-3-id-1-yl]-1,3-thiazole;tetrakis(platinum(2+))
SMILESCn1c(-c2[c-]c3c(cc2)c2ccccc2n3-c2[c-]c(-c3cc(-c4nccs4)ccn3)ccc2)nc2ccccc21.Cn1c(-c2[c-]c3c(cc2)c2ccccc2n3-c2[c-]c(-c3ccc(-c4nccs4)cn3)ccc2)nc2ccccc21.Cn1c(-c2[c-]c3c(cc2)c2ccccc2n3-c2[c-]c(-c3ccccn3)c(-c3nccs3)cc2)nc2ccccc21.Cn1c(-c2[c-]c3c(cc2)c2ccccc2n3-c2[c-]c(-c3ncccc3-c3nccs3)ccc2)nc2ccccc21.[Pt+2].[Pt+2].[Pt+2].[Pt+2]
InChIInChI=1S/4C34H21N5S.4Pt/c1-38-30-14-5-3-12-28(30)37-33(38)23-15-16-26-25-10-2-4-13-29(25)39(31(26)21-23)24-9-6-8-22(20-24)32-27(11-7-17-35-32)34-36-18-19-40-34;1-38-31-12-5-3-10-29(31)37-33(38)23-13-15-27-26-9-2-4-11-30(26)39(32(27)20-23)25-8-6-7-22(19-25)28-16-14-24(21-36-28)34-35-17-18-40-34;1-38-31-12-5-3-10-28(31)37-33(38)23-13-14-27-26-9-2-4-11-30(26)39(32(27)21-23)25-8-6-7-22(19-25)29-20-24(15-16-35-29)34-36-17-18-40-34;1-38-31-12-5-3-10-29(31)37-33(38)22-13-15-25-24-8-2-4-11-30(24)39(32(25)20-22)23-14-16-26(34-36-18-19-40-34)27(21-23)28-9-6-7-17-35-28;;;;/h2-19H,1H3;2-18,21H,1H3;2-18,20H,1H3;2-19H,1H3;;;;/q4*-2;4*+2
InChIKeyGXSIVMMBVLLHGN-UHFFFAOYSA-N
XLogP32.48
TPSA194.12 Ų
H-Bond Donors
H-Bond Acceptors24
Rotatable Bonds16
Heavy Atoms164
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002906.89
LogP ≤ 532.48
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1024

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze 2-[2-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-3-pyridinyl]-1,3-thiazole;2-[2-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-4-pyridinyl]-1,3-thiazole;2-[6-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-3-pyridinyl]-1,3-thiazole;2-[4-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]-2-pyridin-2-ylbenzene-3-id-1-yl]-1,3-thiazole;tetrakis(platinum(2+)) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[2-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-3-pyridinyl]-1,3-thiazole;2-[2-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-4-pyridinyl]-1,3-thiazole;2-[6-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-3-pyridinyl]-1,3-thiazole;2-[4-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]-2-pyridin-2-ylbenzene-3-id-1-yl]-1,3-thiazole;tetrakis(platinum(2+))?
The IUPAC name of 2-[2-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-3-pyridinyl]-1,3-thiazole;2-[2-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-4-pyridinyl]-1,3-thiazole;2-[6-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-3-pyridinyl]-1,3-thiazole;2-[4-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]-2-pyridin-2-ylbenzene-3-id-1-yl]-1,3-thiazole;tetrakis(platinum(2+)) (CID 157122732) is 2-[2-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-3-pyridinyl]-1,3-thiazole;2-[2-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-4-pyridinyl]-1,3-thiazole;2-[6-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-3-pyridinyl]-1,3-thiazole;2-[4-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]-2-pyridin-2-ylbenzene-3-id-1-yl]-1,3-thiazole;tetrakis(platinum(2+)).
What is the SMILES notation for 2-[2-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-3-pyridinyl]-1,3-thiazole;2-[2-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-4-pyridinyl]-1,3-thiazole;2-[6-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-3-pyridinyl]-1,3-thiazole;2-[4-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]-2-pyridin-2-ylbenzene-3-id-1-yl]-1,3-thiazole;tetrakis(platinum(2+))?
The canonical SMILES for 2-[2-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-3-pyridinyl]-1,3-thiazole;2-[2-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-4-pyridinyl]-1,3-thiazole;2-[6-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-3-pyridinyl]-1,3-thiazole;2-[4-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]-2-pyridin-2-ylbenzene-3-id-1-yl]-1,3-thiazole;tetrakis(platinum(2+)) is Cn1c(-c2[c-]c3c(cc2)c2ccccc2n3-c2[c-]c(-c3cc(-c4nccs4)ccn3)ccc2)nc2ccccc21.Cn1c(-c2[c-]c3c(cc2)c2ccccc2n3-c2[c-]c(-c3ccc(-c4nccs4)cn3)ccc2)nc2ccccc21.Cn1c(-c2[c-]c3c(cc2)c2ccccc2n3-c2[c-]c(-c3ccccn3)c(-c3nccs3)cc2)nc2ccccc21.Cn1c(-c2[c-]c3c(cc2)c2ccccc2n3-c2[c-]c(-c3ncccc3-c3nccs3)ccc2)nc2ccccc21.[Pt+2].[Pt+2].[Pt+2].[Pt+2].
What is the InChIKey of 2-[2-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-3-pyridinyl]-1,3-thiazole;2-[2-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-4-pyridinyl]-1,3-thiazole;2-[6-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-3-pyridinyl]-1,3-thiazole;2-[4-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]-2-pyridin-2-ylbenzene-3-id-1-yl]-1,3-thiazole;tetrakis(platinum(2+))?
The InChIKey is GXSIVMMBVLLHGN-UHFFFAOYSA-N. The full InChI is InChI=1S/4C34H21N5S.4Pt/c1-38-30-14-5-3-12-28(30)37-33(38)23-15-16-26-25-10-2-4-13-29(25)39(31(26)21-23)24-9-6-8-22(20-24)32-27(11-7-17-35-32)34-36-18-19-40-34;1-38-31-12-5-3-10-29(31)37-33(38)23-13-15-27-26-9-2-4-11-30(26)39(32(27)20-23)25-8-6-7-22(19-25)28-16-14-24(21-36-28)34-35-17-18-40-34;1-38-31-12-5-3-10-28(31)37-33(38)23-13-14-27-26-9-2-4-11-30(26)39(32(27)21-23)25-8-6-7-22(19-25)29-20-24(15-16-35-29)34-36-17-18-40-34;1-38-31-12-5-3-10-29(31)37-33(38)22-13-15-25-24-8-2-4-11-30(24)39(32(25)20-22)23-14-16-26(34-36-18-19-40-34)27(21-23)28-9-6-7-17-35-28;;;;/h2-19H,1H3;2-18,21H,1H3;2-18,20H,1H3;2-19H,1H3;;;;/q4*-2;4*+2.
What are the key properties of 2-[2-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-3-pyridinyl]-1,3-thiazole;2-[2-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-4-pyridinyl]-1,3-thiazole;2-[6-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-3-pyridinyl]-1,3-thiazole;2-[4-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]-2-pyridin-2-ylbenzene-3-id-1-yl]-1,3-thiazole;tetrakis(platinum(2+))?
2-[2-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-3-pyridinyl]-1,3-thiazole;2-[2-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-4-pyridinyl]-1,3-thiazole;2-[6-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-3-pyridinyl]-1,3-thiazole;2-[4-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]-2-pyridin-2-ylbenzene-3-id-1-yl]-1,3-thiazole;tetrakis(platinum(2+)) has a molecular weight of 2906.89 g/mol, XLogP of 32.48, 16 rotatable bonds, 0 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[2-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-3-pyridinyl]-1,3-thiazole;2-[2-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-4-pyridinyl]-1,3-thiazole;2-[6-[3-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]benzene-2-id-1-yl]-3-pyridinyl]-1,3-thiazole;2-[4-[2-(1-methylbenzimidazol-2-yl)-1H-carbazol-1-id-9-yl]-2-pyridin-2-ylbenzene-3-id-1-yl]-1,3-thiazole;tetrakis(platinum(2+)) is sourced from PubChem (CID 157122732), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).